Estimating clinical outcome of HPV induced cervical lesions by combination of capsid protein L1 and p16INK4a protein detection

Collegium Antropologicum

Volumn 34, Issue 1, 2010, Pages 31-36

  Bolanča, Ines Krivak ^a   Šentija, Karmela ^a   Simon, Suzana Katalenić ^a   Kukura, Vlastimir ^a,c   Vraneš, Jasmina ^b,c  

^a University of Zagreb   (Croatia)

^b Zagreb Institute of Public Health   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Cervical dysplasia; Clinical outcome; Cytology; HPVL1 capsid protein; P16 INK4a

Indexed keywords

CAPSID PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HPV L1 PROTEIN, HUMAN PAPILLOMAVIRUS; ONCOPROTEIN; TUMOR MARKER;

ARTICLE; FEMALE; FOLLOW UP; HUMAN; METABOLISM; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; RISK FACTOR; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR;

CAPSID PROTEINS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FOLLOW-UP STUDIES; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 77952474641     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. PAJTLER M, AUDY-JURKOVIĆ S, KARDIM-SKELIN I, MAHOVLIĆ V, MOZETIĆ-VRDOLJAK D, OVANIN-RAKIĆ A, Coll Antropol, 31 (2007) 47
2. CANTOR SB, ATKINSON EN, CARDENAS-TURANZAS M, BENEDET JL, FOLLEN M, MACAULAY C, Acta Cytol, 49 (2005) 405.
3. VON KNEBEL DOEBERLITZ M, European Journal of Cancer, 38 (2002) 2229.
4. RAUBER D, MEHLHORN G, FASCHING PA, BECKMANN MW, ACKERMANNS, Eur J Obstet Gynecol Reprod Biol, 140 (2008) 258.
5. BAAK JP, KRUSE AJ, Methods Mol Med, 119 (2005) 85.
6. NEGRI G, VITTADELLO F, ROMANO F, Virchows Arch, 445 (2004) 612.
7. HILFRICH R, HARIRI J, Anal Quant Cytol Histol, 30 (2008) 78.
8. GRIESSER H, SANDER H, HILFRICH R, MOSER B, SCHENCK, Anal Quant Cytol Histol, 26 (2004) 241.
9. LJUBOJEVIĆ N, BABIĆ S, AUDY-JURKOVIĆ S, OVANIN-RAKIĆ A, GRUBIŠIĆ G, LJUBOJEVIĆ-GRGEC D, Gynaecol Perinatol, 10 (2001) 53.
10. TRUNK MJ, DALLENBACH-HELLWEG G, RIDDER R, PETRY KU, IKENBERG H, SCHNEIDER V, VON KNEBEL DOEBERITZ M, Acta Cytol, 48 (2004) 771.
11. NANDA K, McCRORY D, MYERS E, BASTIAN L, HASSELBLAD V, HICKEY J, MATCHHAR D, Ann Intern Med, 132 (2000) 810.
12. PATTERSON B, DOMANIK R, WERNKE P, GOMBICH M, Acta Cytol, 45 (2001) 36.
13. CUZICK J, MEIJER CJ, WALBOOMERS JM, Lancet, 351 (1998) 1439.
14. MUNOZ N, J Clin Virol, 19 (2000) 1.
15. ARBYN M, SASIENI P, MEIJER CJ, CLAVEL C, KOLIOPOULOS G, DILLNER J, Vaccine, 24 (2006) 78.
16. KLAES R, FRIEDRICH T, SPITKOVSKY D, RIDDER R, RUDY W, PETRY U, DALLENBACH-HELLWEG G, SCHMIDT D, VON KNEBEL DOEBERITZ M, Int J Cancer, 92 (2001) 276.
17. PIENTONG C, EKALAKSANANAN T, KONGYINGYOES B, KRITPETCHARAT O, SWADPANICH U, PENGSA P, YUENYAO P, Diagn Cytopathol, 31 (2004) 235.
18. NEGRI G, BELLISANO G, ZANNONI GF, RIVASI F, KASAL A, VITTADELLO F, ANTONIAZZI S, FAA G, AMBU R, EGARTET-VIGL E, Am J Surg Pathol, 32 (2008) 1715.
19. DOORBAR J, J Clin Virol, 32 (2005) 7
20. DEHN D, TORKKO KC, SHROYER K, Cancer Cytopathol, 111 (2007) 1.
21. KRIVAK BOLANCA I, CIGLAR S, Coll Anthropol, 31 (2007) 107.
22. YOSHIDA T, SANOV T, KANUMA T, OWADA N, SAKURAI S, FUKUDA T, NAKAJIMA T, Cancer Cytopathol, 114 (2008) 83.
23. MURPHY N, RING M, KELLALEA AG, J Clin Pathol, 56 (2003) 56.